alibaba tirzepatide Lilly's Weight-Loss Drug Approved in China Amid Race With Novo FDA approves Eli Lilly's tirzepatide

This study is investigating whether the dual GIP/GLP-1 agonist tirzepatide (sold as Mounjaro for type 2 diabetes and Zepbound for obesity) can help fight chronic kidney disease in people with obesity with or without type 2 diabetes

Semaglutide didn't play favorites

Role of Physical Activity for Weight Loss and Weight Maintenance

Add checklists for last dose timing, fasting guidance, and escalation if delayed gastric emptying is suspected

Estos ensayos, aunque no diseados primariamente para evaluar eventos cardiovasculares, mostraron tasas consistentemente bajas de eventos adversos cardiovasculares mayores (MACE) en pacientes tratados con tirzepatida comparado con controles activos como insulina o agonistas GLP-1